Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,077 public trials 1,365 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

NCT01041235

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +28 more
Locations: Mary Crowley Cancer Research Centers (MCCRC) Dallas, Texas, United States

Cancer Therapy and Research Center (CTRC) San Antonio, Texas, United States

View Trial Details

Completed

Quality-of-Life Assessment in Patients With Ovarian Cancer

NCT00003772

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations: Landeskrankenhaus/Universitatskliniken Graz Graz, Austria

Centre Alexis Vautrin Vandœuvre-lès-Nancy, France

Hospital De Navarra Pamplona, Spain

Western General Hospital Edinburgh, Scotland, United Kingdom

View Trial Details

Completed

TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary

NCT00296816

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

View Trial Details

Completed

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

NCT00452985

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Sanofi-Aventis Dhaka, Bangladesh

View Trial Details

Completed

Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer

NCT00004081

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

NCT00004861

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Sinai Hospital of Baltimore Baltimore, Maryland, United States

William Beaumont Hospital Royal Oak, Michigan, United States

View all 16 locations

View Trial Details

Completed

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

NCT00003760

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

Brooke Army Medical Center Fort Sam Houston, Texas, United States

San Antonio Cancer Institute San Antonio, Texas, United States

View Trial Details

Completed

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

NCT00165152

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

NCT00501644

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

NCT00059618

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Endocrine Gland Neoplasms

Endocrine Gland Neoplasms trial results

Related conditions